Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Exploring the chemical space of benzothiazole-based DNA gyrase B inhibitors
ID
Skok, Žiga
(
Author
),
ID
Barančokova, Michaela
(
Author
),
ID
Benek, Ondřej
(
Author
),
ID
Durante Cruz, Cristina
(
Author
),
ID
Tammela, Päivi
(
Author
),
ID
Tomašič, Tihomir
(
Author
),
ID
Zidar, Nace
(
Author
),
ID
Peterlin-Mašič, Lucija
(
Author
),
ID
Zega, Anamarija
(
Author
),
ID
Kikelj, Danijel
(
Author
),
ID
Ilaš, Janez
(
Author
)
PDF - Presentation file,
Download
(2,22 MB)
MD5: 2F36CA91727B2E04DE1406F41A26D19F
URL - Source URL, Visit
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00416
URL - Source URL, Visit
https://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.0c00416#
Image galllery
Abstract
We designed and synthesized a series of inhibitors of the bacterial enzymes DNA gyrase and DNA topoisomerase IV, based on our recently published benzothiazole-based inhibitor bearing an oxalyl moiety. To improve the antibacterial activity and retain potent enzymatic activity, we systematically explored the chemical space. Several strategies of modification were followed: varying substituents on the pyrrole carboxamide moiety, alteration of the central scaffold, including variation of substitution position and, most importantly, modification of the oxalyl moiety. Compounds with acidic, basic, and neutral properties were synthesized. To understand the mechanism of action and binding mode, we have obtained a crystal structure of compound 16a, bearing a primary amino group, in complex with the N-terminal domain of E. coli gyrase B (24 kDa) (PDB: 6YD9). Compound 15a, with a low molecular weight of 383 Da, potent inhibitory activity on E. coli gyrase (IC50 = 9.5 nM), potent antibacterial activity on E. faecalis (MIC = 3.13 [micro]M), and efflux impaired E. coli strain (MIC = 0.78 [micro]M), is an important contribution for the development of novel gyrase and topoisomerase IV inhibitors in Gram-negative bacteria.
Language:
English
Keywords:
DNA gyrase
,
topoisomerase IV
,
GyrB
,
ParE
,
antibacterial benzothiazole
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2020
Number of pages:
Str. 2433-2440
Numbering:
Vol. 11, iss. 12
PID:
20.500.12556/RUL-141912
UDC:
615.4:54
ISSN on article:
1948-5875
DOI:
10.1021/acsmedchemlett.0c00416
COBISS.SI-ID:
32932099
Publication date in RUL:
11.10.2022
Views:
619
Downloads:
121
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ACS medicinal chemistry letters
Publisher:
American Chemical Society
ISSN:
1948-5875
COBISS.SI-ID:
2959217
Secondary language
Language:
Slovenian
Keywords:
topoizomeraza IV
,
giraza DNA
,
antibakterijski benzotiazol
,
inibitorji giraze B
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208-2015
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
EC - European Commission
Funding programme:
European Commission
Project number:
642620
Name:
Interdisciplinary Training Network for Validation of Gram-Negative Antibacterial Targets
Acronym:
INTEGRATE
Funder:
Other - Other funder or multiple funders
Funding programme:
Academy of Finland
Project number:
277001
Name:
Phenotypic biosensor-based HTS and mode of action analysis by metabolomics and transcriptomics for enhancing antimicrobial drug discovery against Gram-negative bacteria
Funder:
Other - Other funder or multiple funders
Funding programme:
EU FP7 Integrated Project MAREX
Project number:
FP7-KBBE-2009-3- 245137
Funder:
Other - Other funder or multiple funders
Funding programme:
Wellcome Trust
Project number:
110072/Z/15/Z
Funder:
Other - Other funder or multiple funders
Funding programme:
Biotechnology and Biosciences Research Council (UK) Institute Strategic Programme Grant B
Project number:
BB/P012523/1
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back